The abstract is read at the publisher; the summary is JClub's.
A 65-year-old man with cavin-4 IgG rippling muscle disease achieved complete remission after rituximab therapy.
- Why it matters: Rippling muscle disease can be persistent and difficult to treat, and evidence for effective therapies remains limited.
- What they did: In this case report, the patient received rituximab and was followed to assess disease response.
- The result: Rituximab was linked to complete remission in this patient, suggesting it may be a therapeutic option for cavin-4 IgG rippling muscle disease.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.